ENVB
Enveric Biosciences IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$3.72M
P/E Ratio
—
EPS
$-36.24
Beta
0.33
52W High
$17.84
52W Low
$1.75
50-Day MA
$2.14
200-Day MA
$7.41
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
23.09
PEG Ratio
—
About Enveric Biosciences Inc
Enveric Biosciences, Inc., a pharmaceutical company, is dedicated to developing various cannabinoid drugs for the treatment of cancer. The company is headquartered in Naples, Florida.
Fundamentals
| Revenue (TTM) | $35.41M |
| Gross Profit (TTM) | $8.15M |
| EBITDA | $-8.57M |
| Operating Margin | 0.00% |
| Return on Equity | -304.00% |
| Return on Assets | -134.10% |
| Revenue/Share (TTM) | $37.68 |
| Book Value | $3.94 |
| Price-to-Book | 0.89 |
| Price-to-Sales (TTM) | 0.08 |
| EV/Revenue | 1.758 |
| EV/EBITDA | 0.29 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -7.30% |
| Shares Outstanding | $1.89M |
| Float | $1.85M |
| % Insiders | 3.92% |
| % Institutions | 6.28% |
Historical Volatility
HV 10-Day
78.82%
HV 20-Day
65.29%
HV 30-Day
61.12%
HV 60-Day
91.35%
HV Rank
—
Volatility is currently expanding
Data last updated: 4/15/2026